Literature DB >> 23741546

(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.

Kenzo Uchida1, Hideaki Nakajima, Tsuyoshi Miyazaki, Tatsuro Tsuchida, Takayuki Hirai, Daisuke Sugita, Shuji Watanabe, Naoto Takeura, Ai Yoshida, Hidehiko Okazawa, Hisatoshi Baba.   

Abstract

STUDY
DESIGN: A retrospective study.
PURPOSE: The aims of this study were to investigate the diagnostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in PET/computed tomography (CT) in the evaluation of spinal metastatic lesions. OVERVIEW OF LITERATURE: Recent studies described limitations regarding how many lesions with abnormal (18)F-FDG PET findings in the bone show corresponding morphologic abnormalities.
METHODS: The subjects for this retrospective study were 227 patients with primary malignant tumors, who were suspected of having spinal metastases. They underwent combined whole-body (18)F-FDG PET/CT scanning for evaluation of known neoplasms in the whole spine. (99m)Tc-methylene diphosphonate bone scan was performed within 2 weeks following PET/CT examinations. The final diagnosis of spinal metastasis was established by histopathological examination regarding bone biopsy or magnetic resonance imaging (MRI) findings, and follow-up MRI, CT and (18)F-FDG PET for extensively wide lesions with subsequent progression.
RESULTS: From a total of 504 spinal lesions in 227 patients, 224 lesions showed discordant image findings. For 122 metastatic lesions with confirmed diagnosis, the sensitivity/specificity of bone scan and FDG PET were 84%/21% and 89%/76%, respectively. In 102 true-positive metastatic lesions, the bone scan depicted predominantly osteosclerotic changes in 36% and osteolytic changes in 19%. In 109 true-positive lesions of FDG PET, osteolytic changes were depicted predominantly in 38% while osteosclerotic changes were portrayed in 15%.
CONCLUSIONS: (18)F-FDG PET in PET/CT could be used as a substitute for bone scan in the evaluation of spinal metastasis, especially for patients with spinal osteolytic lesions on CT.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography; Metastasis; Positron emission tomography and computed tomography; Spine; Technetium Tc 99m (Sn)methylenediphosphonate

Year:  2013        PMID: 23741546      PMCID: PMC3669709          DOI: 10.4184/asj.2013.7.2.96

Source DB:  PubMed          Journal:  Asian Spine J        ISSN: 1976-1902


  25 in total

1.  FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.

Authors:  F Moog; J Kotzerke; S N Reske
Journal:  J Nucl Med       Date:  1999-09       Impact factor: 10.057

2.  Spinal involvement of hematopoietic malignancies and metastasis: differentiation using MR imaging.

Authors:  H J Kim; K N Ryu; W S Choi; B K Choi; J M Choi; Y Yoon
Journal:  Clin Imaging       Date:  1999 Mar-Apr       Impact factor: 1.605

3.  Diagnosis of vertebral metastasis, epidural metastasis, and malignant spinal cord compression: are T(1)-weighted sagittal images sufficient?

Authors:  J K Kim; T J Learch; P M Colletti; J W Lee; S D Tran; M R Terk
Journal:  Magn Reson Imaging       Date:  2000-09       Impact factor: 2.546

Review 4.  Evolving role of positron emission tomography in breast cancer imaging.

Authors:  William B Eubank; David A Mankoff
Journal:  Semin Nucl Med       Date:  2005-04       Impact factor: 4.446

Review 5.  Positron emission tomography and bone metastases.

Authors:  Ignac Fogelman; Gary Cook; Ora Israel; Hans Van der Wall
Journal:  Semin Nucl Med       Date:  2005-04       Impact factor: 4.446

6.  Combined PET/CT Imaging in Oncology. Impact on Patient Management.

Authors:  P G. Kluetz; C C. Meltzer; V L. Villemagne; P E. Kinahan; S Chander; M A. Martinelli; D W. Townsend
Journal:  Clin Positron Imaging       Date:  2000-11

7.  CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.

Authors:  Yuji Nakamoto; Christian Cohade; Mitsuaki Tatsumi; Dima Hammoud; Richard L Wahl
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

8.  FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.

Authors:  C Franzius; J Sciuk; H E Daldrup-Link; H Jürgens; O Schober
Journal:  Eur J Nucl Med       Date:  2000-09

9.  Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.

Authors:  Sendhil Kumar Cheran; James E Herndon; Edward F Patz
Journal:  Lung Cancer       Date:  2004-06       Impact factor: 5.705

10.  Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.

Authors:  A C Clavo; R S Brown; R L Wahl
Journal:  J Nucl Med       Date:  1995-09       Impact factor: 10.057

View more
  11 in total

Review 1.  Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI.

Authors:  Ali Batouli; John Braun; Kamal Singh; Ali Gholamrezanezhad; Bethany U Casagranda; Abass Alavi
Journal:  J Neurooncol       Date:  2018-02-26       Impact factor: 4.130

2.  Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.

Authors:  Karsten Beiderwellen; Michael Huebner; Philipp Heusch; Johannes Grueneisen; Verena Ruhlmann; Felix Nensa; Hilmar Kuehl; Lale Umutlu; Sandra Rosenbaum-Krumme; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2014-06-08       Impact factor: 5.315

Review 3.  [18F]FDG-PET Evaluation of Spinal Pathology in Patients in Oncology: Pearls and Pitfalls for the Neuroradiologist.

Authors:  P Y Patel; I Dalal; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-28       Impact factor: 3.825

4.  Differential diagnostic value of 18F-FDG PET/CT in osteolytic lesions.

Authors:  Xiaomeng Li; Ning Wu; Wenjie Zhang; Ying Liu; Yue Ming
Journal:  J Bone Oncol       Date:  2020-07-13       Impact factor: 4.072

5.  Mandibular metastasis of cholangiocarcinoma: A case report.

Authors:  Tae Min You; Kee-Deog Kim; Ho-Gul Jeong; Wonse Park
Journal:  Imaging Sci Dent       Date:  2015-12-17

6.  A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.

Authors:  Lin Zhang; Lihua Chen; Qiao Xie; Yongke Zhang; Lin Cheng; Haitao Li; Jian Wang
Journal:  BMC Med Imaging       Date:  2015-03-01       Impact factor: 1.930

7.  Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management.

Authors:  Fatma Ahmed; Razi Muzaffar; Hermina Fernandes; Yifan Tu; Batool Albalooshi; Medhat M Osman
Journal:  Front Oncol       Date:  2016-10-10       Impact factor: 6.244

8.  Interesting Skeletal Radiologic and Scintigraphic Outcomes and Their Logical Clinical Conclusions.

Authors:  Ranadheer Manthri; Tejonath Gadepalli; Deepthi Pathapati; Vvs Prabhakar Rao
Journal:  Indian J Nucl Med       Date:  2017 Oct-Dec

9.  Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis.

Authors:  Guoqiang Shao; Wei Gu; Muhong Guo; Shiming Zang; Jinjing Fu; Shuang Liu; Feng Wang; Zizheng Wang
Journal:  Oncotarget       Date:  2017-04-27

10.  What is the Diagnostic Performance of 18F-FDG-PET/MRI in the Detection of Bone Metastasis in Patients with Breast Cancer?

Authors:  Filiz Çelebi
Journal:  Eur J Breast Health       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.